≡ Risteys
R8

Documentation Changelog GitHub Contact & Feedback

Alzheimer’s disease (Atypical or mixed)

DOID EFO MESH SNOMED PheWeb

AD_AM

Alzheimer's disease: A progressive, neurodegenerative disease characterized by loss of function and death of nerve cells in several areas of the brain leading to loss of cognitive function such as memory and language.

Endpoint definition

↥
FinnGen phenotype data

356077 individuals

diagram downward connector

Apply sex-specific rule None

356077

diagram downward connector

Check conditions None

356077

diagram downward connector
diagram bullet

Filter registries

Hospital Discharge: ICD-10 F00.24*, G30.8, G30.8+F00.20
Hospital discharge: ICD-9 $!$
Hospital discharge: ICD-8 $!$
Cause of death: ICD-10 F00.24*, G30.8, G30.8+F00.20
Cause of death: ICD-9 $!$
Cause of death: ICD-8 $!$

1764

diagram downward connector
diagram bullet

Check pre-conditions, main-only, mode, ICD version

Look only at ICD versions H.D: 10, 8, 9 ; C.O.D: 10, 8, 9

1764

diagram downward connector

Check minimum number of events None

1764

diagram downward connector

Include endpoints None

1764

diagram downward connector
AD_AM

Extra metadata

First used in FinnGen datafreeze DF2

Summary Statistics

↥

Key figures

All Female Male
Number of individuals 1764 684 1080
Unadjusted prevalence (%) 0.50 0.34 0.69
Mean age at first event (years) 80.70 81.23 80.36

Mortality

Follow-up Absolute risk HR [95% CI] p N
1998–2019 0.20 12.84 [9.64, 17.11] 3.7e-68 984
15 years 0.01 1.73 [1.26, 2.38] 7.9e-4 127
5 years - - - -
1 year - - - -

Age distribution of first events

Year distribution of first events

Cumulative Incidence

Correlations

↥

Index endpoint: AD_AM – Alzheimer’s disease (Atypical or mixed)
GWS hits:

Survival analyses between endpoints

↥

Plot

before Alzheimer’s disease (Atypical or mixed)
after Alzheimer’s disease (Atypical or mixed)

loading spinner Loading survival analyses plot

Drugs most likely to be purchased after Alzheimer’s disease (Atypical or mixed)

↥